文献速递淋巴瘤白血病

慢性淋巴细胞白血病向Richter综合征转化的基因组与转录组关联研究

Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
PubMed 文献 · Blood · 2021-01-01

本研究对17例入组CHOP-O临床试验患者的配对循环CLL与Richter综合征活检组织进行全基因组测序,发现组织-RS富集不良预后CLL驱动基因及DNA损伤应答通路突变,并鉴定PTPRD、TRAF3等新发畸变及非编码区kataegis;RNA表达谱在独立队列中验证MAPK与DDR通路差异表达。

要点

  • 组织-RS富集不良预后CLL驱动基因及DNA损伤应答通路突变。
  • 鉴定PTPRD、TRAF3等既往未涉及RS的基因组畸变及非编码区kataegis。
  • MAPK与DDR通路基因显示高克隆扩增概率,独立队列RNA表达验证。

核心结论

  • 组织-RS富集不良预后CLL驱动基因和DDR通路基因突变,DDR是驱动转化的主要机制。
  • 鉴定PTPRD、TRAF3等新发RS相关畸变及非编码区kataegis影响免疫调控基因。
  • MAPK和DDR通路基因具有高克隆扩增概率,独立队列RNA表达谱验证差异表达。

研究设计与样本

  • 对17例入组CHOP-O临床试验患者的配对循环CLL与RS活检组织进行全基因组测序。
  • 整合WGS与RNA表达数据,并在独立队列中比较淋巴结CLL与组织-RS配对样本的RNA表达谱。
  • 试验注册号NCT03899337。

主要发现

  • 组织-RS富集不良预后CLL驱动基因及DNA损伤应答通路基因突变。
  • 发现PTPRD和TRAF3等既往未涉及RS的基因组畸变。
  • 非编码基因组中发现AID相关及非相关kataegis,影响BTG2、CXCR4、NFATC1、PAX5、NOTCH-1、SLC44A5、FCRL3、SELL、TNIP2和TRIM13等免疫调控基因调控区。
  • 配对PB-CLL与组织-RS样本整体突变特征差异提示DDR是驱动转化的主要机制。
  • 通路克隆去卷积分析显示MAPK和DDR通路基因具有高克隆扩增概率,独立队列RNA表达谱验证相同通路差异表达。

临床怎么用

  • 整合WGS与RNA表达分析有助于识别RS转化的新基因组关联,为治疗靶点选择提供依据。
  • 结果可为英国临床平台研究未来候选药物选择提供参考。

局限性

  • 样本量较小(17例配对样本),结论需更大队列验证。
  • 既往靶向方法因缺乏胚系样本受限,本研究虽整合WGS与RNA表达但仍需功能验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The transformation of chronic lymphocytic leukemia (CLL) to high-grade B-cell lymphoma is known as Richter syndrome (RS), a rare event with dismal prognosis. In this study, we conducted whole-genome sequencing (WGS) of paired circulating CLL (PB-CLL) and RS biopsies (tissue-RS) from 17 patients recruited into a clinical trial (CHOP-O). We found that tissue-RS was enriched for mutations in poor-risk CLL drivers and genes in the DNA damage response (DDR) pathway. In addition, we identified genomic aberrations not previously implicated in RS, including the protein tyrosine phosphatase receptor (PTPRD) and tumor necrosis factor receptor-associated factor 3 (TRAF3). In the noncoding genome, we discovered activation-induced cytidine deaminase-related and unrelated kataegis in tissue-RS affecting regulatory regions of key immune-regulatory genes. These include BTG2, CXCR4, NFATC1, PAX5, NOTCH-1, SLC44A5, FCRL3, SELL, TNIP2, and TRIM13. Furthermore, differences between the global mutation signatures of pairs of PB-CLL and tissue-RS samples implicate DDR as the dominant mechanism driving transformation. Pathway-based clonal deconvolution analysis showed that genes in the MAPK and DDR pathways demonstrate high clonal-expansion probability. Direct comparison of nodal-CLL and tissue-RS pairs from an independent cohort confirmed differential expression of the same pathways by RNA expression profiling. Our integrated analysis of WGS and RNA expression data significantly extends previous targeted approaches, which were limited by the lack of germline samples, and it facilitates the identification of novel genomic correlates implicated in RS transformation, which could be targeted therapeutically. Our results inform the future selection of investigative agents for a UK clinical platform study. This trial was registered at www.clinicaltrials.gov as #NCT03899337.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Klintman J, Appleby N, Stamatopoulos B, et al. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood. 2021. PMID: 33206936. doi:10.1182/blood.2020005650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。